Clinical Observation of Yiqi Huoxue Jiedu herbs in Improving the Prognosis of Stable Coronary Heart Disease

Xiyuan Hospital, China Academy of Chinese Medical Sciences0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1.Meets the diagnostic criteria for stable coronary heart disease
•2.Aged between 18-75 years
•3.Meets the criteria of moderate or severe angina (CCS classification II, III) or meets at least 2 conditions in 4 conditions including Hs-CRP>3mg/L, high blood pressure (classification II-III), high cholesterol history, and diabetes history
•4.singed the consent form

•1. Combined with other heart diseases, or severe cardiopulmonary insufficiency (heart function level III or higher, severe pulmonary insufficiency);
•2. Combined with Acute cerebrovascular disease;
•3. Combined with uncontrolled blood pressure(systolic blood pressure =160mmHg and diastolic blood pressure =100mmHg);
•4. Combined with malignant arrhythmia (ventricular tachycardia, supraventricular arrhythmia affecting hemodynamics) which repeated attacks recently;
•5. Combined with severe primary diseases such as liver, kidney, and hematopoietic system, acute infectious diseases, and mental illness;
•6. Pregnant, planning to get pregnant or lactating women;
•7. Have done head, chest and abdominal operation and bleeding tendency in the past 4 week;
•8. Participated in other clinical trials in the past 1 month;
•9. Allergic constitution or allergic to the known ingredients of the test drug.

发起方